Morgan Stanley Sees Risk to Consensus Estimates Skew Positive for UTi Worldwide

In a report published Tuesday, Morgan Stanley analyst William J. Greene reiterated an Equal-Weight rating on

. In the report, Morgan Stanley noted, “While top-line and gross margin correlations are mixed, normal seasonality suggests cons. F2Q15 EBITDA estimates are conservative with incremental cost savings serving as an additional source of upside. We're raising F2Q15 our EPS ests from $0.03/shr. to $0.04/shr. vs. cons of $0.01/shr.” UTi Worldwide closed on Friday at $9.18.